Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05596331 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Social Information Processing in Children: an ocUlo-pupillometric Tool for Standard Evaluation

Study acronym: SIRCUS
StatusRecruiting
PhaseNot applicable
Started2023-01-03
View on ClinicalTrials.gov ↗

Amendment history

2026-08-25
Study Status v3
Completion pushed: 2026-09 → 2026-11-02
2023-12-04
Not Yet Recruiting→Recruiting Study Status, Outcome Measures, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2026-09→2026-01-03
Start dateestimated 2022-11→confirmed 2023-01-03
Study sites0→1
2022-11-09
Study Identification, Study Status, Arms and Interventions, Outcome Measures, Eligibility, Contacts/Locations v1
Primary endpoints6 entries, revised
Oculometric measurements n°1: Tracking time Oculometric measurements n°2: Fixation time on the screen Oculometric measurements n°3: Fixation time on the eye area during entire stimuli duration Oculometric measurements n°4: Fixation time on the mouth area of face stimuli
2022-10-24
Original filing
The goal of this observational study is to identify behavioral and physiological markers of social alterations in Autism Spectrum Disorders compared to Typically Developping peers. This single-centre study plan to use eye tracking to evaluate social disorders in Autism Spectrum Disorders (ASD). The investigators will estimate oculometric and pupillometric indices as potential ASD biomarkers. The study will last 4 years and will be organized in two phases.
Trial Details
NCT Number NCT05596331
Lead Sponsor University Hospital, Tours
Collaborators: UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., Laboratory of Fundamental and Applied Computer Science of Tours, EA6300, National Research Agency, France, Ministry of Health, France
Conditions Autism Spectrum Disorder
Enrollment 460 participants
Start Date 2023-01-03
Primary Completion 2026-01-03 (estimated)
Study Completion 2026-11-02 (estimated)
Updated on ClinicalTrials.gov 2026-08-28